Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Colloral oral tolerance treatment: Began Phase II trial

AutoImmune Inc. (AIMM), Lexington, Mass.

Read the full 57 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE